Evidence map›Paper›PMID 39018187›Full record

ArticleBioinformatics (Oxford, England)2024

q2-metnet: QIIME2 package to analyse 16S rRNA data via high-quality metabolic reconstructions of the human gut microbiota.

Francesco Balzerani, Telmo Blasco, Sergio Pérez-Burillo, M Pilar Francino, José Á Rufián-Henares, Luis V Valcarcel, Francisco J Planes

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Recent advances in precision nutrition and cardiometabolic diseases.Revista espanola de cardiologia (English ed.) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesco BalzeraniTecnun School of Engineering, Biomedical Engineering and Sciences Department, University of Navarra, San Sebastian 20018, Spain.
Telmo BlascoTecnun School of Engineering, Biomedical Engineering and Sciences Department, University of Navarra, San Sebastian 20018, Spain.
Sergio Pérez-BurilloTecnun School of Engineering, Biomedical Engineering and Sciences Department, University of Navarra, San Sebastian 20018, Spain.ORCID 0000-0001-6398-7496
M Pilar FrancinoArea de Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana-Salud Pública, Valencia, 46020, Spain.
José Á Rufián-HenaresDepartamento de Nutrición y Bromatología, Instituto de Nutrición y Tecnología de los Alimentos, Centro de Investigación Biomédica, Universidad de Granada, Granada, 18071, Spain.
Luis V ValcarcelTecnun School of Engineering, Biomedical Engineering and Sciences Department, University of Navarra, San Sebastian 20018, Spain.ORCID 0000-0003-3769-5419
Francisco J PlanesTecnun School of Engineering, Biomedical Engineering and Sciences Department, University of Navarra, San Sebastian 20018, Spain.ORCID 0000-0003-1155-3105

Funding

European Union's Horizon 2020 research and innovation programme
6 · The paper itself

Abstract

motivation16S rRNA gene sequencing is the most frequent approach for the characterization of the human gut microbiota. Despite different efforts in the literature, the inference of functional and metabolic interpretations from 16S rRNA gene sequencing data is still a challenging task. High-quality metabolic reconstructions of the human gut microbiota, such as AGORA and AGREDA, constitute a curated resource to improve functional inference from 16S rRNA data, but they are not typically integrated into standard bioinformatics tools.

resultsHere, we present q2-metnet, a QIIME2 plugin that enables the contextualization of 16S rRNA gene sequencing data into AGORA and AGREDA. In particular, based on relative abundances of taxa, q2-metnet determines normalized activity scores for the reactions and subsystems involved in the selected metabolic reconstruction. Using these scores, q2-metnet allows the user to conduct differential activity analysis for reactions and subsystems, as well as exploratory analysis using PCA and hierarchical clustering. We apply q2-metnet to a dataset from our group that involves 16S rRNA data from stool samples from lean, allergic to cow's milk, obese and celiac children, and the Belgian Flemish Gut Flora Project cohort, which includes faecal 16S rRNA data from obese and normal-weight adult individuals. In the first case, q2-metnet outperforms existing algorithms in separating different clinical conditions based on predicted pathway abundances and subsystem scores. In the second case, q2-metnet complements competing approaches in predicting functional alterations in the gut microbiota of obese individuals. Overall, q2-metnet constitutes a powerful bioinformatics tool to provide metabolic context to 16S rRNA data from the human gut microbiota. AVAILABILITY AND IMPLEMENTATION: Python code of q2-metnet is available in https://github.com/PlanesLab/q2-metnet and https://figshare.com/articles/dataset/q2-metnet_package/26180446.

Indexed as

Gastrointestinal MicrobiomeRNA, Ribosomal, 16SSoftwareComputational BiologyHumansRNA, Ribosomal, 16S

Identifiers

PMID39018187
PMCPMC11561042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.